seperator

Pipeline Status

seperator

Ethris’ initial focus is to leverage our pioneering SNIM® RNA technology platform to develop therapies for respiratory diseases with high unmet medical need. Beyond this, the versatility of our first-in-class biopharmaceutical platform for replacing or augmenting missing or non-functional proteins will ultimately enable us to address an array of diverse diseases.

Learn more about our technology.

GO TO TECHNOLOGY